Currently, PCa screening is based in serum prostate specific antigen (PSA) test and digital rectal examination (DRE) [4], whereas prostate biopsy (PB) is mandatory for a final diagnosis [5]. This evidence concerns the gene KLK3 and posterior cortical atrophy.